目的 梳理国内外药品个人进口计划的相关法规与案例,立足我国国情提出改进建议,为完善我国个人进口药品管理提供借鉴。方法 采用文献分析与政策分析相结合的方法对药品个人进口计划的实现形式、相关法规、作用与相关风险等进行归纳比较。结果 药品个人进口计划主要包括两种形式:个人携药入境和通过第三方购药,其适用范围在各国家有不同的规定,目前在多个国家均有实践案例。药品个人进口计划的实施具有两面性,在帮助患者更快用上境外新药和廉价药的同时,应注意药品质量和用药安全的隐患。结论 中国目前关于药品个人进口计划缺乏相关法律法规。建议针对个人进口药品建立安全监管体系;亟待完善海南进口药品先行区的相关政策,构建从进口到使用的药品保障路径;建立个人进口药品国际健康险衔接制度。
Abstract
OBJECTIVE To sort out relevant laws & regulations of domestic & foreign personal importation schemes and provide suggestions and reference for the improvement of China′s management of personal drug-importation. METHODS Literature analysis and policy analysis were used to summarize and compare the implementation forms, relevant laws & regulations, and effect and relevant risks of personal drug-importation schemes. RESULTS Personal importation schemes mainly exists in two forms: individual drugs entry and purchase through a third party. Different countries have different regulations, based on its application scope. Personal importation scheme has been successfully applied in many countries. The scheme is a double-edged sword, which can help patients to get new imported drugs and cheap drugs earlier. However, more attention should be paid to drug quality and patient safety. CONCLUSION Currently, there are no detailed regulations on personal importation scheme of drugs in China. It is suggested that relevant laws & regulations need to be improved urgently. The safety supervision system of personal importation scheme of drugs needs to be established. To construct the supportive approach from import to use based on the pilot area of import drugs in Hainan, and establish international health insurance reimbursement system of personal drug-importation schemes.
关键词
药品个人进口计划 /
药品可及性 /
安全风险 /
法律 /
法规
{{custom_keyword}} /
Key words
drug personal importation schemes /
drug accessibility /
safety risk /
laws /
regulations
{{custom_keyword}} /
中图分类号:
R95
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] WANG Q H, HUANG R Q, LI F, et al. Systematic review of new drug research and development (R&D) cost[J]. Chin New Drugs J(中国新药杂志), 2020, 29(6):601-608.
[2] FENG H Y. Analysis on the influence of overseas drug purchase by Chinese on domestic pharmaceutical industry[J]. Pract Foreign Econ Relat Trade(对外经贸实务), 2016(9):86-88.
[3] Therapeutic Goods Administration. Personal importation scheme [EB/OL]. (2015-03-18) [2020-06-06]. https://www.tga.gov.au/personal-importation-scheme.
[4] Food and Drug Administration. Information on Importation of Drugs Prepared by the Division of Import Operations and Policy, FDA[EB/OL]. (2015-09-25) [2020-06-06]. https://www.fda.gov/industry/import-program-food-and-drug-administration-fda/importations-drugs.
[5] Swedish. Medical Products Agency. Travelling with medicines[EB/OL]. (2020-06-05) [2020-09-13]. https://www. lakemedelsverket. se/en/behandling-och-forskrivning/buy-use-and-handle-medicines/travelling-with-medicines.
[6] Swissmedic. Guideline on medicines and the Internet[EB/OL]. (2019-01-21) [2020-06-08]. https://www. swissmedic. ch/swissmedic/en/home/humanarzneimittel/market-surveillance/medicinal-products-from-the-internet/leitfaden-arzneimittel-aus-dem-internet. html#accordion1591623045357.
[7] New Zealand Medicines and Medical Devices Safety Authority. Personal Importation of Medicines. [EB/OL]. (2018-10-08) [2020-09-07]. https://medsafe. govt. nz/Consumers/MIET/ImportMedicines. asp.
[8] Ellen′t Hoen. The Italian Exception-A personalised approach to accessing high-priced patented medicines[EB/OL]. (2017-05-05) [2020-06-07]. https://medicineslawandpolicy.org/2017/05/the-italian-exception-a-personalised-approach-to-access-to-high-priced-patented-medicines/.
[9] Medicines and Healthcare Products Regulatory Agency. MHRA-Information about buying prescription drugs from Internet Pharmacies (UD)[EB/OL]. (2014-03-23) [2020-09-07]. https://www.tpauk.com/main/article/mhra-information-about-buying-prescription-drugs-from-internet-pharmacies-ud/.
[10] KEITH A. Generic hepatitis C drugs purchased online achieve high cure rates.[EB/OL]. (2016-10-27) [2020-07-05]. https://www.aidsmap.com/news/oct-2016/generic-hepatitis-c-drugs-purchased-online-achieve-high-cure-rates.
[11] ZHANG Y. Why India is the pharmacy of the world for generics[J]. China Economic Weekly(中国经济周刊), 2018(28):62-65.
[12] IYENGAR S, TAY-TEO K, VOGLER S, et al. Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis[J]. PLoS Med, 2016, 13(5):e1002032.
[13] The Kirby Institute. Monitoring hepatitis C treatment uptake in Australia[EB/OL]. [2020-09-16]. https://kirby. unsw. edu. au/sites/default/files/kirby/report/Monitoring-hep-C-treatment-uptake-in-Australia_Iss8-DEC17. pdf.
[14] DANTA M, GHINEA N. The complex legal and ethical issues related to generic medications. Viral hepatitis: a case study[J]. J Virus Erad, 2017, 3(2):77-81.
[15] UCHIYAMA N, KAMAKURA H, MASADA S, et al. Chemical analysis of counterfeit hepatitis C drug found in Japan[J]. Yakugaku Zasshi, 2017, 137(10):1265-1276.
[16] RAHMAN M S, YOSHIDA N, TSUBOI H, et al. Erroneous formulation of delayed-release omeprazole capsules: alert for importing countries[J]. BMC Pharmacol Toxicol, 2017, 18(1):31.
[17] RAHMAN M S, YOSHIDA N, SUGIURA S, et al. Quality of omeprazole purchased via the Internet and personally imported into Japan: comparison with products sampled in other Asian countries[J]. Trop Med Int Health, 2018, 23(3):263-269.
[18] ZWAR N. Travelling with medicines in 2018[J]. Aust Prescr, 2018, 41(4):102-104.
[19] FANG W Y. There are many safety risks in purchasing drugs from overseas[J]. China Anti-Counterfeiting Report(中国防伪报道), 2014,(2):55.
[20] The Office of Hainan Provincial Party Committee Free Trade Port. To create a clinical urgent need for domestic unlisted imported drugs regulatory mode[EB/OL]. (2019-12-23) [2020-07-05]. http://www.hnftp.gov.cn/zdcx/cxal/202002/t20200224_3260510.html.
[21] KANKANNEWS. Boao Hope City launched a global special drug insurance 29 yuan covering 70 kinds of special drugs[EB/OL]. (2020-08-02) [2020-09-16]. http://www.kankanews.com/a/2020-08-02/0039480250.shtml.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金青年项目资助(71804032)
{{custom_fund}}